RIFAMYCIN B

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C39H49NO14
Molecular Weight	755.8047
Optical Activity	UNSPECIFIED
Defined Stereocenters	9 / 9
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C4=C(OCC(O)=O)C=C(NC(=O)C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C

InChI

InChIKey=SQTCRTQCPJICLD-KTQDUKAHSA-N

InChI=1S/C39H49NO14/c1-17-11-10-12-18(2)38(49)40-24-15-26(51-16-27(42)43)28-29(34(24)47)33(46)22(6)36-30(28)37(48)39(8,54-36)52-14-13-25(50-9)19(3)35(53-23(7)41)21(5)32(45)20(4)31(17)44/h10-15,17,19-21,25,31-32,35,44-47H,16H2,1-9H3,(H,40,49)(H,42,43)/b11-10+,14-13+,18-12-/t17-,19+,20+,21+,25-,31-,32+,35+,39-/m0/s1

HIDE SMILES / InChI

Approval Year

PubMed

Title	Date	PubMed
The rifamycins.	1963	13948282

Patents

Name

Type

Language

RIFAMYCIN B

Common Name

English

NSC-145604

Code

English

RIFAMYCIN B [MI]

Common Name

English

4-O-(CARBOXYMETHYL)RIFAMYCIN

Common Name

English

NANCIMYCIN

Common Name

English

((2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-(ACETYLOXY)-5,6,17,19-TETRAHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,11-DIOXO-1,2-DIHYDRO-2,7-(EPOXYPENTADECA(1,11,13)TRIENAZANO)NAPHTHO(2,1-B)FURAN-9-YL)ACETIC ACID

Systematic Name

English

RIFAXIMIN IMPURITY B [EP IMPURITY]

Common Name

English

RIFAMYCIN SODIUM IMPURITY A [EP IMPURITY]

Common Name

English

Code System Code Type Description

CHEBI

58306